Envoy Medical (COCH) Convertible Debt (2022 - 2023)
Envoy Medical's (COCH) quarterly Convertible Debt came in at $2.5 million in Q4 2023, down 92.51% year-on-year from $33.4 million in Q4 2022, and down 37.5% quarter-over-quarter from $4.0 million in Q3 2023.
Envoy Medical (COCH) Convertible Debt (2022 - 2023) Analysis & Trends
Envoy Medical has disclosed Convertible Debt across 2 years of filings, most recently posting $2.5 million for Q4 2023.
- Convertible Debt for Q4 2023 came in at $2.5 million, down 92.51% year-over-year; the trailing twelve-month figure through Dec 2023 was $2.5 million (down 92.51% YoY), and the FY2023 annual result was $2.5 million, down 92.51% from the prior year.
- Convertible Debt came in at $2.5 million for Q4 2023 at Envoy Medical, down from $4.0 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $33.4 million in Q4 2022 to a low of $2.5 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Envoy Medical | 44.81 Mn | 19.56 Mn | -274,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.50 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 14.70 Mn |
| Dec 31, 2022 | 33.40 Mn |